Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity - PubMed

Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity

R P Kosman et al. Proteins. 1993 Feb.

Abstract

The X-ray crystal structure of CTP-ligated T state aspartate transcarbamoylase has been refined to an R factor of 0.182 at 2.5 A resolution using the computer program X-PLOR. The structure contains 81 sites for solvent and has rms deviations from ideality in bond lengths and bond angles of 0.018 A and 3.722 degrees, respectively. The cytosine base of CTP interacts with the main chain carbonyl oxygens of rTyr-89 and rIle-12, the main chain NH of rIle-12, and the amino group of rLys-60. The ribose hydroxyls form polar contacts with the amino group of rLys-60, a carboxylate oxygen of rAsp-19, and the main chain carbonyl oxygen of rVal-9. The phosphate oxygens of CTP interact with the amino group of rLys-94, the hydroxyl of rThr-82, and an imidazole nitrogen of rHis-20. Recent mutagenesis experiments evaluated in parallel with the structure reported here indicate that alterations in the hydrogen bonding environment of the side chain of rAsn-111 may be responsible for the homotropic behavior of the pAR5 mutant of ATCase. The location of the first seven residues of the regulatory chain has been identified for the first time in a refined ATCase crystal structure, and the proximity of this portion of the regulatory chain to the allosteric site suggests a potential role for these residues in nucleotide binding to the enzyme. Finally, a series of amino acid side chain rearrangements leading from the R1 CTP allosteric to the R6 CTP allosteric site has been identified which may constitute the molecular mechanism of distinct CTP binding sites on ATCase.

Similar articles

• A single mutation in the regulatory chain of Escherichia coli aspartate transcarbamoylase results in an extreme T-state structure.

  Williams MK, Stec B, Kantrowitz ER. Williams MK, et al. J Mol Biol. 1998 Aug 7;281(1):121-34. doi: 10.1006/jmbi.1998.1923. J Mol Biol. 1998. PMID: 9680480

• Crystal structure of Sulfolobus acidocaldarius aspartate carbamoyltransferase in complex with its allosteric activator CTP.

  De Vos D, Xu Y, Aerts T, Van Petegem F, Van Beeumen JJ. De Vos D, et al. Biochem Biophys Res Commun. 2008 Jul 18;372(1):40-4. doi: 10.1016/j.bbrc.2008.04.173. Epub 2008 May 12. Biochem Biophys Res Commun. 2008. PMID: 18477471

• Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH.

  Gouaux JE, Stevens RC, Lipscomb WN. Gouaux JE, et al. Biochemistry. 1990 Aug 21;29(33):7702-15. doi: 10.1021/bi00485a020. Biochemistry. 1990. PMID: 2271529

• From feedback inhibition to allostery: the enduring example of aspartate transcarbamoylase.

  Gerhart J. Gerhart J. FEBS J. 2014 Jan;281(2):612-20. doi: 10.1111/febs.12483. Epub 2013 Sep 5. FEBS J. 2014. PMID: 23953008 Review.

• Escherichia coli aspartate transcarbamylase: the relation between structure and function.

  Kantrowitz ER, Lipscomb WN. Kantrowitz ER, et al. Science. 1988 Aug 5;241(4866):669-74. doi: 10.1126/science.3041592. Science. 1988. PMID: 3041592 Review.

Cited by

• Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.

  Coudray L, Pennebaker AF, Montchamp JL. Coudray L, et al. Bioorg Med Chem. 2009 Nov 15;17(22):7680-9. doi: 10.1016/j.bmc.2009.09.045. Epub 2009 Sep 30. Bioorg Med Chem. 2009. PMID: 19828320 Free PMC article.

• The pathway of product release from the R state of aspartate transcarbamoylase.

  Mendes KR, Kantrowitz ER. Mendes KR, et al. J Mol Biol. 2010 Sep 3;401(5):940-8. doi: 10.1016/j.jmb.2010.07.003. Epub 2010 Jul 8. J Mol Biol. 2010. PMID: 20620149 Free PMC article.

• A cooperative Escherichia coli aspartate transcarbamoylase without regulatory subunits.

  Mendes KR, Kantrowitz ER. Mendes KR, et al. Biochemistry. 2010 Sep 7;49(35):7694-703. doi: 10.1021/bi1010333. Biochemistry. 2010. PMID: 20681545 Free PMC article.

• The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

  Tuchman M, Morizono H, Reish O, Yuan X, Allewell NM. Tuchman M, et al. J Med Genet. 1995 Sep;32(9):680-8. doi: 10.1136/jmg.32.9.680. J Med Genet. 1995. PMID: 8544185 Free PMC article.

• Conversion of the allosteric regulatory patterns of aspartate transcarbamoylase by exchange of a single beta-strand between diverged regulatory chains.

  Liu L, Wales ME, Wild JR. Liu L, et al. Biochemistry. 1997 Mar 18;36(11):3126-32. doi: 10.1021/bi962065d. Biochemistry. 1997. PMID: 9115988 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Molecular Biology Databases

  • Saccharomyces Genome Database